Sab Biotherapeutics, Inc. · NASDAQ:SABS
Rtw Investments, LP's stake in Sab Biotherapeutics, Inc. fell to 3.20% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Rtw Investments, LP's stake in Sab Biotherapeutics, Inc. fell to 3.20%, 1,587,302 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 3.20%
- Shares
- 1,587,302
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RTW Investments, LP | 3.20% | 1,587,302 |
| Roderick Wong | 3.20% | 1,587,302 |
Source
Related
- Sab Biotherapeutics, Inc.
- Rtw Investments, LP
- Sab Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Rtw Investments, LP · Feb 14, 2025
- Form 4 · Kropotova Alexandra · Sep 18, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026